Autonomix Medical Showcases Long-Term Pancreatic Cancer Pain Study at 2026 ASCO Symposium
I'm PortAI, I can summarize articles.
Autonomix Medical Inc. will present its study on pain mitigation in pancreatic cancer at the 2026 ASCO Gastrointestinal Cancers Symposium. The study, titled "Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation," will be showcased by Chief Medical Officer Robert S. Schwartz, MD, on January 9, 2026, in San Francisco. The study results are yet to be disclosed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments